Does Wegovy Interfere with the Menstrual Cycle?

What the STEP trials and prescribing information actually record

The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults without diabetes over 68 weeks and produced some of the strongest weight-loss data seen for a licensed medicine. Changes to the menstrual cycle were not listed as a primary outcome, and the Wegovy Summary of Product Characteristics does not include menstrual irregularity among the adverse effects observed at a statistically meaningful frequency above placebo. That might sound reassuring, and in one sense it is: semaglutide itself does not appear to act directly on the reproductive hormones that govern your cycle.

But trials are not the whole picture. Reproductive endocrinologists have documented for decades that weight loss of even 5–10% of body weight can shift oestrogen levels enough to alter cycle length, flow, and regularity. Wegovy produces average losses well above that threshold for many participants, and it does so relatively quickly. The hormone disruption is real; the mechanism is metabolic rather than pharmacological. This distinction matters because it means symptoms tend to settle as weight stabilises, rather than persisting indefinitely.

A question our prescribers hear most weeks is whether a missed or very different period means something has gone wrong with treatment. Usually it does not. But the same question is worth raising with your GP if bleeding is very heavy, if cycles remain absent after several months, or if you have a known reproductive-health condition that could be affected by hormonal shifts.

Polycystic ovary syndrome, fertility, and why early contraception matters

Women with polycystic ovary syndrome may notice particularly pronounced changes. PCOS is closely linked to insulin resistance and excess androgens; weight loss can restore ovulation in women who had not been ovulating regularly, sometimes ahead of any visible normalisation in cycle pattern. This is not a side effect of Wegovy. It is a consequence of improved metabolic health. It is also why the NHS England guidance on weight-management injections is clear that contraception should be used by women of childbearing age on these medicines, and should be in place from the outset.

Wegovy is not recommended during pregnancy or breastfeeding, and women trying to conceive are advised to stop treatment and allow time for the medicine to clear before attempting conception. Your prescriber can advise on the appropriate interval. The point is not to be alarmist: restored ovulation is, for many women with PCOS, a welcome change. The practical implication is simply that pregnancy becomes possible sooner than expected, so reliable contraception is not optional.

On the question of which contraceptive to use: semaglutide slows gastric emptying, which theoretically could affect absorption of oral contraceptives. Current NHS guidance does not flag the same specific warning that exists for tirzepatide, but if you want to understand how semaglutide interacts with contraception in more detail, that page covers the evidence and practical recommendations.

How quickly do cycle changes appear, and when do they settle?

Most women who report menstrual changes notice them in the first two to three months of treatment, coinciding with the period of fastest weight loss and the dose-escalation phase. Cycles often become more irregular initially, then gradually stabilise as the rate of weight change slows and the body adjusts to its new hormonal baseline.

There is no set timeline that applies to everyone. Age, starting weight, how quickly weight comes off, whether PCOS or other reproductive conditions are present, and the dose reached all play a role. Some women report that periods that were previously irregular, painful, or very heavy actually improve over the course of treatment, which fits the known relationship between obesity, inflammation, and gynaecological symptoms. You can read more about how Wegovy affects menstruation more broadly, including what heavier or lighter bleeding typically means in this context.

If changes are bothering you, or if you are unsure whether what you are experiencing is expected, the right step is a conversation with your GP or the prescriber who oversees your treatment, not an adjustment to your dose. Questions about how semaglutide affects the cycle are best answered with your full medical history in front of the clinician.

Getting the most from treatment alongside any menstrual changes

Cycle changes rarely require stopping Wegovy. They are worth monitoring and discussing, not suffering in silence. Keeping a simple note of cycle dates during the first few months makes that conversation with a prescriber much easier. You can explore the broader picture of what Wegovy involves as a treatment, including how the dose-escalation schedule works and what other physical changes people notice early on.

Nutrition during treatment also interacts with hormonal health. Adequate protein, iron (especially if bleeding is heavier than usual), and calorie intake above very low thresholds all matter for reproductive hormone production. A structured nutrition plan alongside Wegovy is worth considering, particularly if you are eating significantly less than before. The goal is weight loss that works with your body's other systems, not against them.

If you are weighing up options and thinking about costs, our guide to Wegovy pricing in the UK explains the market context honestly. And if you would like to start a clinical conversation about whether Wegovy is right for your situation, our prescribers review consultations personally and are available seven days a week. Speak to our prescribers and get a same-day clinical review from a GPhC-registered Independent Prescriber.